Yanan Bicon Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder: The 2022 Annual General Meeting of Shareholders (hereinafter referred to as "the Meeting") has been postponed, with the new meeting date set for May 25, 2023, instead of the originally scheduled May 19, 2023. The record date for shareholding remains unchanged at May 15, 2023, and other details such as the meeting location, method, agenda, and registration procedures will remain the same.